Navigation Links
Version 2.0 of Prostate Cancer Risk Calculator now online, complete with emojis
Date:8/4/2014

SAN ANTONIO (August 4, 2014) A calculator to help men and their doctors assess their risk of prostate cancer, developed at the UT Health Science Center, has had a major upgrade to enhance how men and their physicians better understand a man's risk of prostate cancer. A description of the update's needs and benefits is described by the Health Science Center authors in a viewpoint published online Monday in the Journal of the American Medical Association.

"The prostate cancer risk calculator has been updated using current risk factors and a better interface; the current version gives a more nuanced result that helps understand a man's risk of prostate cancer," said Ian M. Thompson Jr., M.D., director of the Cancer Therapy & Research Center at the UT Health Science Center, who helped develop the risk calculator and co-authored a commentary published today in the Journal of the American Medical Association.

The free calculator on the Health Science Center website takes just minutes to use and gives a man more information about his risk for both low-grade prostate cancer, which may never require treatment, and high-grade prostate cancer. It provides an "emoji" graphic readout that puts the numeric percentages into a visual perspective. Significantly, it also gives the possibility in numbers (and emojis) that he may have no prostate cancer at all.

"What is important are the three numbers," Dr. Thompson said. "For doctors, it makes for a more challenging conversation with the patient. For the patient, it gives him better information so he can decide how he wants to move forward."

The primary purpose of assessing prostate cancer risk is detection of high-grade, high risk cancers. "The prostate cancers you want to find are the high-grade cancers," Dr. Thompson said, "because then we can take action to prolong and even save a man's life."

"On the other hand, in some men, a prostate biopsy will far more commonly find a low-grade cancer. These cancers have such a low risk that many men who take the time to fully understand the options, decide to simply monitor them", says Dr. Thompson. "For many men who have been diagnosed with these low-risk cancers, they wish they'd known about that before they had a prostate biopsy; many, in retrospect wish they'd not had a biopsy in the first place. This new risk calculator helps them understand that risk in advance."

The risk calculator is based on data from the 18,882-man National Cancer Institute's Prostate Cancer Prevention Trial (PCPT), a national multi-site study of which Dr. Thompson was original principal investigator. The first risk calculator was made available in 2006, but Dr. Thompson said as screening and treatment affects more and more of the population, it changes the risk factors that affect the calculations. The CTRC scientific team has continued to update the calculator since 2006.

"The new calculator should provide a more accurate prediction of the outcome that a man would expect on biopsy because it incorporates a substantially larger amount of patient data than the original calculator," said Donna Ankerst, Ph.D., research professor of urology at the Health Science Center and professor of mathematics at the Technical University in Munich, who helped develop the calculator. "It also uses an advanced statistical model to distinguish the prediction of low-grade and high-grade disease."

Along with building on the knowledge that continues to come from data in the Prostate Cancer Prevention Trial, the new calculator also incorporates data from a separate study conducted by Dr. Thompson. That study, called San Antonio Center of Biomarkers Of Risk for Prostate Cancer (SABOR) gave the researchers a new biomarker called percent-free PSA.

"Step by step, we are assembling the tools to help men work with their doctors to make better-informed decisions about their treatment," Dr. Thompson said. "And, as steps go, this is a big one."


'/>"/>

Contact: Elizabeth Allen
210-450-2020
University of Texas Health Science Center at San Antonio
Source:Eurekalert  

Related medicine news :

1. FDA Approves Generic Versions of Plavix
2. FDA Warns of Fake Version of ADHD Drug Adderall
3. Version 2.0 of Award-Winning Proloquo2Go App for iPhone, iPad & iPod touch Speeds Up Communication, Adds New Voices and Customization Options
4. HealthLine Systems’ is Pleased to Announce Release of Echo Version 5.0
5. FDA Issues Another Warning on Fake Version of Cancer Drug Avastin
6. Harmonic Software Systems Announces an Updated Version of Their DigitalMeds iPhone App
7. Stark Mobile Technologies LLC is Pleased to Announce a Fresh, New Version of GuySpy for the iPhone.
8. Dr. Mike Hamilton of Inception Chiropractic Websites Announces the Release of Conversion Optimized Chiropractic Websites
9. EcoVim Food Waste Reduction & Conversion System to Debut at Columbia Business School Symposium
10. EcoVim Organic Food Waste Reduction & Conversion System to Debut at Westchester County’s Food Rescue Forum
11. Heart Attack Preventing Drug, Plavix, Poses Continued Risk While Bristol-Myers Squibb Extends the Rights to Others for Generic OTC Versions
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Version 2.0 of Prostate Cancer Risk Calculator now online, complete with emojis
(Date:1/21/2017)... ... January 21, 2017 , ... "ProDOF is the perfect set of tools for video editors that ... a scene," said Christina Austin - CEO of Pixel Film Studios. , Video editors ... the illusion of a DSLR racking focus from one area into the next. ProDOF ...
(Date:1/21/2017)... , ... January 21, 2017 , ... ... its new medical office in Petaluma, located at 167 Lynch Creek Way. The ... to SRO sports medicine and rehabilitation services and on-site x-ray services. ...
(Date:1/20/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh has posted a ... Yisrayl says this generation is a time like no other and society needs to understand ... Yisrayl says he does not want to sound like an old bible beater because religion ...
(Date:1/20/2017)... ... January 20, 2017 , ... ... to enhance people’s everyday lives, recently attended the January ECRM Trade Show in ... Science is known for its large range of supplements that keep the body ...
(Date:1/20/2017)... ... January 20, 2017 , ... “Mary Magdalene: Grace is Greater than Sin”: ... woman who witnessed Jesus Christ firsthand. “Mary Magdalene: Grace is Greater than Sin” is ... as an educator interacting with countless women who had little knowledge of the female ...
Breaking Medicine News(10 mins):
(Date:1/20/2017)... 2017 Avillion LLP, a co-developer and financier ... Weinberg , MD MBA as Chief Medical Officer. Dr Weinberg will ... . ... Weinberg has spent more than 17 years as a pharmaceutical and ... micro-cap biotech. Over the course of his career, he has interfaced ...
(Date:1/19/2017)... , Jan. 19, 2017 The Global Therapy ... and access to partnering deals and agreements entered into ... in partnering deals - Top deals by value - ... development, technology type The report provides understanding and ... by the world,s leading healthcare companies. The report ...
(Date:1/19/2017)... , Jan. 19, 2017 This report ... current and future scenario of the global market. Large ... opioid consumption. Severe chronic constipation is a major side ... traditional laxatives. Hence, novel targeted therapy has been prescribed ... sufferers, launch of targeted medicines, and growing awareness about ...
Breaking Medicine Technology: